Open AccessRechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma
Author(s) -
Jiani Wang,
Quan-Hui Qiao,
Xingsheng Hu,
Yutao Liu,
Zhijie Wang,
Jianchun Duan,
Yue Feng,
Haohua Zhu
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001511
Subject(s) - pemetrexed , medicine , chemotherapy , adenocarcinoma , oncology , lung , lung cancer , adenocarcinoma of the lung , intensive care medicine , cancer , cisplatin